34 participants
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-01
- Start Date:
- 2024-08-07
- Completion:
- 2029-12-31
Conditions
- Glioblastoma
Interventions
- DRUG
- DEVICE
No Results Yet